How to Test Human-Specific Combination Immunotherapies In Vivo
Por um escritor misterioso
Descrição
Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.
STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models
Cancers, Free Full-Text
Humanized Mouse Model Head to Head: hPBMC vs hCD34+
Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine: Molecular Therapy - Methods & Clinical Development
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Engineering patient-specific cancer immunotherapies
Two is better than one: combining bispecific antibodies for signal 1 and signal 2
Enhancing anti-tumour efficacy with immunotherapy combinations - The Lancet
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
Antibodies, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
